How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,334 results for

Myocardial Infarction Stabilization

Latest & greatest

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

301. Adalimumab (Halimatoz) - Juvenile Rheumatoid Arthritis, Psoriatic Arthritis, Rheumatoid Arthritis, Hidradenitis Suppurativa, Psoriasis, Ankylosing Spondylitis, Uveitis

standards as well as the concept for introduction of future in-house reference standards has been briefly outlined. Release and periodical retests for both, the primary reference and the working reference standard have been submitted and are considered acceptable. For the primary reference standard a panel of analytical methods for additional characterisation has been presented. Stability The proposed shelf life of Halimatoz active substance when stored at the recommended conditions is based on long (...) -term stability data. The results demonstrate that Halimatoz active substance is stable under the recommended conditions. Supporting information on accelerated and stress stability data and data from thermal freeze/thaw cycles as well as photo-stability data have been provided. Comparability exercise for Active Substance The development activities include the initial development of the AS manufacturing process, the following scale up and transfer from the pilot scale to the manufacturing scale

2018 European Medicines Agency - EPARs

302. Nitroglycerin

ration via nasogastric tube. In 4 groups of 5 horses each, saline (0.9% NaCl) solution or ET receptor antagonist (10(5)M 2006 2. Prehospital Nitroglycerin Safety in Inferior ST Elevation Myocardial Infarction. Patients with inferior ST elevation myocardial infarction (STEMI), associated with right ventricular infarction, are thought to be at higher risk of developing hypotension when administered nitroglycerin (NTG). However, current basic life support (BLS) protocols do not differentiate location (...) (or ) are indicated as first line agents in most other cases of III. Preparation Mix 50 mg in 250 ml D5W IV. Dosing: Acute Myocardial Ischemia or Infarction Bolus: 12.5 to 25 mcg 2015 16. Nitroglycerin Nitroglycerin Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies

2018 Trip Latest and Greatest

303. Quinapril

angiotensin (...) -converting enzyme inhibition (ACE-I) (i.e., quinapril ) prevents transient ischemia (exertional and spontaneous) in patients with coronary artery disease (CAD). It is known that ACE-I reduces the risk of death, myocardial infarction (MI), and other CAD-related outcomes in high-risk patients. Numerous studies have confirmed that ACE-I improves coronary flow and endothelial function. Whether ACE-I also decreases transient ischemia is unclear, because no studies have been adequately (...) of systematic reviews, clinical guidelines 2018 12. Effects of quinapril , losartan and hydralazine on cardiac hypertrophy and β-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats 9504380 1998 04 13 1998 04 13 2015 11 19 0007-1188 123 3 1998 Feb British journal of pharmacology Br. J. Pharmacol. Effects of quinapril , losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats. 405-12 1. Desensitization of the myocardial beta

2018 Trip Latest and Greatest

304. ESC/ESH Management of Arterial Hypertension Full Text available with Trip Pro

Rosuvastatin LDH Lactate dehydrogenase LDL-C LDL cholesterol LEAD Lower extremity artery disease LIFE Losartan Intervention For Endpoint reduction in hypertension LV Left ventricular LVH Left ventricular hypertrophy MAP Mean arterial pressure MI Myocardial infarction MR Magnetic resonance MRA Mineralocorticoid receptor antagonist MRI Magnetic resonance imaging MUCH Masked uncontrolled hypertension NORDIL Nordic Diltiazem NS Non-significant NT-proBNP N-terminal pro-B natriuretic peptide o.d. Omni die (every (...) million), and ischaemic stroke (1.5 million). Both office BP and out-of-office BP have an independent and continuous relationship with the incidence of several CV events [haemorrhagic stroke, ischaemic stroke, myocardial infarction, sudden death, heart failure, and peripheral artery disease (PAD)], as well as end-stage renal disease. Accumulating evidence is closely linking hypertension with an increased risk of developing atrial fibrillation (AF), and evidence is emerging that links early elevations

2018 European Society of Cardiology

306. Sodium zirconium cyclosilicate (Lokelma) - Hyperkalemia

are usually between 3.5 and 5.0 mmol/L, which is considered the normal range for adults. However, a number of recent retrospective studies have shown the risk of mortality is increased even with only modest elevations of S-K. Mortality risk has been shown to be significantly higher in chronic kidney disease (CKD) patients with S-K levels > 5.0 mmol/L. In acute myocardial infarction patients, a mean postadmission S-K = 5.5 mmol/L during hospitalisation corresponded to a 12-fold increase in death compared (...) of the active substance are provided. The results are within the specifications and consistent from batch to batch. The active substance specifications are based on the active substance critical quality attributes (CQA). Stability Stability data on six commercial scale batches of the active substance from the proposed manufacturer stored in a container closure system representative of that intended for commercial production were provided. Data on three batches was provided for 24 months under long term

2018 European Medicines Agency - EPARs

307. Ertugliflozin l-pyroglutamic acid / metformin hydrochloride (Segluromet) - Diabetes Mellitus, Type 2

through extensive form screening experiments and crystallization studies and is the only form of ertugliflozin L-PGA. All batches of ertugliflozin L-PGA have been consistent. In addition, confirmation of form has been evaluated as part of the supportive and primary stability programs (36 months & 12 months at 25 °C/60% RH; respectively) using powder x-ray diffraction (PXRD) with no changes being observed. Ertugliflozin L-PGA is a white to off-white powder. Ertugliflozin is very slightly soluble (...) testing has been presented. Batch analysis data from full scale batchesof the active substance are provided. The results are within the specifications and consistent from batch to batch. Stability Stability data from full scale batches of active substance from the proposed manufacturer, stored in the intended commercial package for up to 12 months under long term conditions (25 ºC / 60% RH) and for up to 6 months under accelerated conditions (40 ºC / 75% RH) according to the ICH guidelines were

2018 European Medicines Agency - EPARs

308. Effectiveness of interventions to reduce homelessness: a systematic review and meta?analysis Full Text available with Trip Pro

, once per week, 2) the intervention is described as standard or broker case management, or 3) where intensity was not described. Housing programs Housing programs for homeless people typically provide accommodation and include goals such as long term residential stability, improved life‐skills and greater self‐determination (20, 21). These programs are complex and may include various forms of support and services, such as case management, work therapy, treatment of mental illness and substance abuse (...) , there have been many evaluations of housing and treatment programs for homeless individuals and/or persons at risk of homelessness. Several reviews and meta‐analyses have also been published (12, 18, 20, 28‐31). Yet, a large share of the reviews are out of date, or do not focus on homelessness and residential stability as primary outcomes, or are not systematic reviews of effectiveness. Tabol and colleagues (2010) (12) aimed to determine how clearly the supported/supportive housing model is described

2018 Campbell Collaboration

310. Reducing Acute Care Length of Stay in Newfoundland & Labrador

of treatment or care in a plan, pathway, algorithm, guideline, protocol or other 'inventory of actions;' ? the intervention had timeframes or criteria-based progression; and ? the intervention aimed to standardize care for a specific clinical problem, procedure or episode of healthcare in a specific population (2) Early Discharge (ED) Interventions initiated during the acute phase of an illness or injury to facilitate transition of care back to the community as soon as the acute event is stabilized (3

2018 Newfoundland and Labrador Centre for Health Information

311. Remote Patient Monitoring

:// Service User/Eligibility Delivery Model Service Providers Partners Involved Patient or System Outcomes Cost ? Telehomecare services are aimed at clients with one or more complex and / or chronic conditions whose ongoing monitoring helps to maintain and / or stabilize their state of health. ? Health monitoring services are accessed via an online app or a dedicated app installed on patient’s computer, tablet, or smart phone (for the online app). ? As needed, a tablet (iPad) can

2018 Newfoundland and Labrador Centre for Health Information

312. Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD

with stable COPD or patients who had stabilized after an episode of ECOPD, but in more recent times, a number of trials have explored the role of exercise/early pulmonary rehabilitation during an episode of ECOPD. 27, 28 Chest physiotherapy using airway clearance techniques (including breathing technique, vibration/percussion, and autogenic drainage) are used routinely in many patients hospitalized with ECOPD. A Cochrane review published in 2012 found evidence that airway clearance techniques may reduce

2019 Effective Health Care Program (AHRQ)

313. Patients Hospitalized with Heart Failure: Risk Assessment, Management, and Clinical Trajectory

. -,NO. -,2019 Hollenberg et al. -,2019:-–- Heart Failure Hospitalization Pathway 9TABLE 4 Key Comorbid Conditions to Consider Comorbidity Management Relevant Guidelines/Pathways Cardiovascular Coronary artery disease/acute coronary syndrome Assess and treat ischemia, and consider revascularization. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction Atrial ?brillation/ ?utter (...) chain; ARB¼ angiotensin receptor blockers; ATTR¼ amyloid transthyretin; GDMT¼ guideline-directed medical therapy; HF¼ heart failure; HFrEF¼ heart failure with reduced ejection fraction; HTN¼ hypertension; RAAS¼ renin-angiotensin-aldosterone system; SGLT2¼ sodium-glucose cotransporter-2; STEMI¼ ST-segment elevation myocardial infarction. JACC VOL. -,NO. -,2019 Hollenberg et al. -,2019:-–- Heart Failure Hospitalization Pathway 11trial databases are continuous variables, while those from administrative

2019 American College of Cardiology

318. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part I: Review of Anticoagulation Agents and Clinical Considerations Full Text available with Trip Pro

of thrombosis. It is used in patients without verified vascular disease and to reduce the risk of vascular events in patients at high risk or those with a history of myocardial infarction or stroke. Aspirin irreversibly inhibits cyclooxygenase (COX)-1, resulting in reduced thromboxane A2 production, which subsequently decreases platelet aggregation and activation. Aspirin has a mild antiplatelet effect, acts within 15–30 minutes, and is rapidly metabolized into its nonactive metabolite. The lifespan (...) P2Y12 inhibitor that has a rapid onset of action with a short half-life of 3–6 minutes. It is used in acute coronary care for the prevention of periprocedural myocardial infarction or stent thrombosis, with patients being transitioned to an oral thienopyridine agent postprocedurally. Cangrelor can also be used as a “bridge” therapy option for patients receiving oral thienopyridines before surgery ( x 38 Angiolillo, D.J., Firstenberg, M.S., Price, M.J , and BRIDGE Investigators. Bridging antiplatelet

2019 Society of Interventional Radiology

319. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part II: Recommendations. Full Text available with Trip Pro

) ( x 13 Lane, D.A. and Lip, G.Y. Use of the CHADS-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation. Circulation . 2012 ; 126 : 860–865 ) (13) . The acryonm represents underlying cardiovascular risk factors used to calculate the score: congestive hear failiure (C), hypertension (H), age (A), diabetes (D), stroke/transient ischemic attack (S), and vascular diseases (VASc) such as peripheral arterial disease, previous myocardial infarction (...) of thrombotic risk, especially when newly implanted ( x 18 Dangas, G.D., Weitz, J.I., Giustino, G., Makkar, R., and Mehran, R. Prosthetic heart valve thrombosis. J Am Coll Cardiol . 2016 ; 68 : 2670–2689 ) (18) . Coronary Artery Disease As discussed in part I of these guidelines, significant morbidity and potential for thromboembolic complications exist if such patients are mismanaged ( x 20 Windecker, S., Kolh, P., Alfonso, F. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force

2019 Society of Interventional Radiology

320. Telehealth for Acute and Chronic Care Consultations

department; EMS = emergency medical services; KQ = Key Question; RR = risk ratio; STEMI = ST-elevation myocardial infarction; tPA = tissue plasminogen activator; Outpatient Telehealth Consultations • Clinical outcomes: Clinical outcomes were reported in just over one-quarter of the studies of telehealth consultations and in 7 of 11 clinical topics. In three topics, there is moderate strength of evidence of the benefits of telehealth (better healing in wound care, higher response to treatment

2019 Effective Health Care Program (AHRQ)

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>